| Scallop genome provides insights into evolution of bilaterian karyotype and development S Wang, J Zhang, W Jiao, JI Li, X Xun, Y Sun, X Guo, P Huan, B Dong, ... Nature ecology & evolution 1 (5), 0120, 2017 | 370 | 2017 |
| Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC) Y Kong, L Cheng, F Mao, Z Zhang, Y Zhang, E Farah, J Bosler, Y Bai, ... Journal of Biological Chemistry 293 (37), 14328-14341, 2018 | 97 | 2018 |
| p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer J Liu, D He, L Cheng, C Huang, Y Zhang, X Rao, Y Kong, C Li, Z Zhang, ... Oncogene 39 (19), 3939-3951, 2020 | 86 | 2020 |
| Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer Y Bai, Z Zhang, L Cheng, R Wang, X Chen, Y Kong, F Feng, N Ahmad, ... Journal of Biological Chemistry 294 (25), 9911-9923, 2019 | 71 | 2019 |
| Plk1 phosphorylation of Mre11 antagonizes the DNA damage response Z Li, J Li, Y Kong, S Yan, N Ahmad, X Liu Cancer research 77 (12), 3169-3180, 2017 | 65 | 2017 |
| NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells E Farah, C Li, L Cheng, Y Kong, NA Lanman, P Pascuzzi, GR Lorenz, ... Journal of Biological Chemistry 294 (21), 8543-8554, 2019 | 58 | 2019 |
| Targeting Plk1 to enhance efficacy of olaparib in castration-resistant prostate cancer J Li, R Wang, Y Kong, MM Broman, C Carlock, L Chen, Z Li, E Farah, ... Molecular cancer therapeutics 16 (3), 469-479, 2017 | 57 | 2017 |
| Hsp70 gene expansions in the scallop Patinopecten yessoensis and their expression regulation after exposure to the toxic dinoflagellate Alexandrium catenella J Cheng, X Xun, Y Kong, S Wang, Z Yang, Y Li, D Kong, S Wang, L Zhang, ... Fish & shellfish immunology 58, 266-273, 2016 | 55 | 2016 |
| Plk1 inhibition enhances the efficacy of BET epigenetic reader blockade in castration-resistant prostate cancer F Mao, J Li, Q Luo, R Wang, Y Kong, C Carlock, Z Liu, BD Elzey, X Liu Molecular cancer therapeutics 17 (7), 1554-1565, 2018 | 41 | 2018 |
| Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer J Li, R Wang, PG Schweickert, A Karki, Y Yang, Y Kong, N Ahmad, ... Cell Cycle 15 (5), 711-719, 2016 | 41 | 2016 |
| Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice Z Li, J Liu, J Li, Y Kong, G Sandusky, X Rao, Y Liu, J Wan, X Liu Journal of Biological Chemistry 292 (42), 17461-17472, 2017 | 38 | 2017 |
| The genome-wide identification of mitogen-activated protein kinase kinase (MKK) genes in Yesso scallop Patinopecten yessoensis and their expression responses to bacteria challenges J Zou, R Wang, R Li, Y Kong, J Wang, X Ning, L Zhang, S Wang, X Hu, ... Fish & shellfish immunology 45 (2), 901-911, 2015 | 32 | 2015 |
| Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancer X Chen, J Liu, L Cheng, C Li, Z Zhang, Y Bai, R Wang, T Han, C Huang, ... The Prostate 80 (3), 256-266, 2020 | 26 | 2020 |
| Solute carriers in scallop genome: Gene expansion and expression regulation after exposure to toxic dinoflagellate X Xun, J Cheng, J Wang, Y Li, X Li, M Li, J Lou, Y Kong, Z Bao, X Hu Chemosphere 241, 124968, 2020 | 20 | 2020 |
| Plk1-mediated phosphorylation of TSC1 enhances the efficacy of rapamycin Z Li, Y Kong, L Song, Q Luo, J Liu, C Shao, X Hou, X Liu Cancer research 78 (11), 2864-2875, 2018 | 20 | 2018 |
| Inhibition of EZH2 enhances the antitumor efficacy of metformin in prostate cancer Y Kong, Y Zhang, F Mao, Z Zhang, Z Li, R Wang, J Liu, X Liu Molecular cancer therapeutics 19 (12), 2490-2501, 2020 | 19 | 2020 |
| A requirement of Polo-like kinase 1 in murine embryonic myogenesis and adult muscle regeneration Z Jia, Y Nie, F Yue, Y Kong, L Gu, TP Gavin, X Liu, S Kuang Elife 8, e47097, 2019 | 15 | 2019 |
| DNA damage response-independent role for MDC1 in maintaining genomic stability Z Li, C Shao, Y Kong, C Carlock, N Ahmad, X Liu Molecular and cellular biology, 2017 | 15 | 2017 |
| The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RET Y Kong, DB Allison, Q Zhang, D He, Y Li, F Mao, C Li, Z Li, Y Zhang, ... Science signaling 15 (754), eabj4009, 2022 | 11 | 2022 |
| Epigenetics in prostate cancer treatment K Jones, Y Zhang, Y Kong, E Farah, R Wang, C Li, X Wang, ZZ Zhang, ... Journal of translational genetics and genomics 5, 341, 2021 | 10 | 2021 |
